Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of Wednesday, August 5, 2026.
EV/EBITDA RATIO
N/A
Market Cap
$1.26B
EV/EBITDA Ratio
14.76x
TTM Avg
38.26x
3Y Avg
235.00x
5Y Avg
235.00x
Market Cap
$2.64B
EV/EBITDA Ratio
29.39x
TTM Avg
38.46x
3Y Avg
90.12x
5Y Avg
90.12x
Market Cap
$2.76B
EV/EBITDA Ratio
8.62x
TTM Avg
7.69x
3Y Avg
39.44x
5Y Avg
28.37x
Market Cap
$7.06B
EV/EBITDA Ratio
81.84x
TTM Avg
64.93x
3Y Avg
315.58x
5Y Avg
315.58x
Market Cap
$7.81B
EV/EBITDA Ratio
139.61x
TTM Avg
113.60x
3Y Avg
54.60x
5Y Avg
54.60x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $468.68M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $440.37M | 22.12x | 14.44x | 15.00x | 16.68x |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.26B | 14.76x | 38.26x | 235.00x | 235.00x |
| TransMedics Group, Inc. (TMDX)vs › | $2.64B | 29.39x | 38.46x | 90.12x | 90.12x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.76B | 8.62x | 7.69x | 39.44x | 28.37x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | 81.84x | 64.93x | 315.58x | 315.58x |
| Oscar Health, Inc. (OSCR)vs › | $7.81B | 139.61x | 113.60x | 54.60x | 54.60x |
| Tempus AI, Inc. (TEM)vs › | $8.18B | N/A | N/A | N/A | N/A |
| Insulet Corp. (PODD)vs › | $9.23B | 15.46x | 33.76x | 49.53x | 90.37x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
